Ligand-receptor analyses suggest the CCL17-CCR4 axis mediates chemoattraction in myeloid-enriched IPF subsets [179], and these subsets are responsive to pirfenidone. Here, CCL17 is linked to idiopathic pulmonary fibrosis.